0001209191-23-035589.txt : 20230608
0001209191-23-035589.hdr.sgml : 20230608
20230608204606
ACCESSION NUMBER: 0001209191-23-035589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCDADE MARK
CENTRAL INDEX KEY: 0001242126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40655
FILM NUMBER: 231003606
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 7442 NORTH MARCER WAY
CITY: MERCER ISLAND
STATE: WA
ZIP: 98040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 737-0085
MAIL ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-06
0
0001786255
Icosavax, Inc.
ICVX
0001242126
MCDADE MARK
C/O QIMING U.S. VENTURES MANAGEMENT, LLC
11100 NE 8TH STREET, SUITE 200
BELLEVUE
WA
98004
1
0
0
0
0
Stock Option (Right to Buy)
9.89
2023-06-06
4
A
0
17000
0.00
A
2033-06-05
Common Stock
17000
17000
D
The option shall vest in equal monthly installments over the twelve (12) months following the date of grant (or, in the event the next annual meeting of the Company's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Company's stockholders), subject to continued service through the applicable vesting date.
/s/ Mark McDade
2023-06-08